Gubra A/S

    Jurisdiction
    Denmark
    LEI
    254900T17RRFZONO6W53
    ISIN
    DK0062266474 (GUBRA.CO)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A

    Profile

    Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €63.03M
    Gross margin
    59.4%
    EBIT
    -€13.17M
    EBIT margin
    -20.9%
    Net income
    -€10.85M
    Net margin
    -17.2%

    Statement period: - (published )

    Dividends

    Last dividend amount
    DKK 61.20
    Ex date
    Payment date

    Add to watchlist

    Notifications